Cargando…
Using Real-World Data to Predict Clinical and Economic Benefits of a Future Drug Based on its Target Product Profile
INTRODUCTION: For a new drug to be developed, the desired properties are described in a target product profile. OBJECTIVE: We propose a framework for using real-world data to measure the disease-specific costs of the current standard of care and then to project the costs of the proposed new product...
Autores principales: | Gerlinger, Christoph, Evers, Thomas, Rassen, Jeremy, Wyss, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392984/ https://www.ncbi.nlm.nih.gov/pubmed/32533499 http://dx.doi.org/10.1007/s40801-020-00203-w |
Ejemplares similares
-
The Role of Real‐World Evidence in FDA‐Approved New Drug and Biologics License Applications
por: Purpura, Christina A., et al.
Publicado: (2021) -
Real-world persistence and benefit–risk profile of fingolimod over 36 months in Germany
por: Ziemssen, Tjalf, et al.
Publicado: (2019) -
Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection
por: Harvey, Raymond A., et al.
Publicado: (2020) -
Real world data on symptomology and diagnostic approaches of 27,840 women living with endometriosis
por: Becker, Kerstin, et al.
Publicado: (2021) -
Real world economic outlook : the legacy of globalization : debt and deflation /
Publicado: (2003)